Clinical Trial

USCOM in Newly Diagnosed FGR Cases

Study acronym: USCOM FGR
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated February 10, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this research study is to study the use of an ultrasound measurement system (USCOM) for patients with newly diagnosed fetal growth restriction (FGR). This system uses a technology to measure how much blood is being pumped in and out of the heart, which is important for understanding the heart's function in relation to pregnancy.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06343051
Lead Sponsor Icahn School of Medicine at Mount Sinai
Conditions Fetal Growth Restriction, USCOM
Enrollment 100 participants
Start Date 2024-07-02
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-02-10